Lacosamide Krka (Lacosamide)

Lacosamide works by enhancing the slow inactivation of voltage‑gated sodium channels, which limits repetitive neuronal firing. It also modulates the protein CRMP2, further stabilizing neuronal excitability and contributing to seizure control.

The appropriate dose of Lacosamide Krka is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any relevant renal or hepatic considerations. Patients should follow the prescriber’s instructions exactly.

Safety data for lacosamide in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation and modulating CRMP2—differs from many traditional anticonvulsants that target fast inactivation. This can offer an alternative for patients who have not achieved adequate control with other agents, though individual response varies.

Lacosamide Krka tablets should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date.

Lacosamide Krka is taken orally, usually with or without food, as directed by the prescriber. The tablets are swallowed whole with a glass of water and should be taken at the same times each day to maintain consistent blood levels.

Serious risks include cardiac conduction abnormalities such as PR‑interval prolongation, potential suicidal thoughts or behavior, severe skin reactions like Stevens‑Johnson syndrome, and rare hypersensitivity reactions. Patients should seek immediate medical attention if they experience any of these symptoms.

Lacosamide is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is also advised for individuals with significant cardiac conduction disorders, severe renal or hepatic impairment, and those taking medications that markedly affect its metabolism.